Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing

Hypertens Res. 2024 Dec 23. doi: 10.1038/s41440-024-02055-1. Online ahead of print.
No abstract available

Keywords: Angiotensin; Coronavirus; Hypotension; Valsartan.

Publication types

  • Letter